{"id":"https://openalex.org/W2590172458","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.411","title":"Discovery and validation of the nuclear export protein CRM1 (XPO1) as a new target for the treatment of renal cell carcinoma (RCC).","display_name":"Discovery and validation of the nuclear export protein CRM1 (XPO1) as a new target for the treatment of renal cell carcinoma (RCC).","publication_year":2013,"publication_date":"2013-02-20","ids":{"openalex":"https://openalex.org/W2590172458","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.411","mag":"2590172458"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.6_suppl.411","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.411","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.6_suppl.411","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079170443","display_name":"Hiromi Inoue Wettersten","orcid":"https://orcid.org/0000-0001-7144-3122","observed_orcids":["https://orcid.org/0000-0001-7144-3122"]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hiromi Inoue Wettersten","raw_affiliation_strings":["University of California, Davis, Davis, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Davis, Davis, CA","institution_ids":["https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112906141","display_name":"Michael G. Kauffman","orcid":"https://orcid.org/0000-0001-5643-0200","observed_orcids":["https://orcid.org/0000-0001-5643-0200"]},"institutions":[{"id":"https://openalex.org/I4210152529","display_name":"Karyopharm Therapeutics (United States)","ror":"https://ror.org/04ty78924","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152529"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Kauffman","raw_affiliation_strings":["Karyopharm Therapeutics, Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karyopharm Therapeutics, Newton, MA","institution_ids":["https://openalex.org/I4210152529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051352882","display_name":"Sharon Shacham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152529","display_name":"Karyopharm Therapeutics (United States)","ror":"https://ror.org/04ty78924","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152529"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon Shacham","raw_affiliation_strings":["Karyopharm Therapeutics, Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karyopharm Therapeutics, Newton, MA","institution_ids":["https://openalex.org/I4210152529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057755017","display_name":"Yosef Landesman","orcid":"https://orcid.org/0000-0001-5542-5098","observed_orcids":["https://orcid.org/0000-0001-5542-5098"]},"institutions":[{"id":"https://openalex.org/I4210152529","display_name":"Karyopharm Therapeutics (United States)","ror":"https://ror.org/04ty78924","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152529"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yosef Landesman","raw_affiliation_strings":["Karyopharm Therapeutics, Natick, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karyopharm Therapeutics, Natick, MA","institution_ids":["https://openalex.org/I4210152529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086066594","display_name":"Joy C. Yang","orcid":"https://orcid.org/0000-0001-9162-481X","observed_orcids":["https://orcid.org/0000-0001-9162-481X"]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joy Yang","raw_affiliation_strings":["University of California, Davis, Davis, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Davis, Davis, CA","institution_ids":["https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christopher Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Evans","raw_affiliation_strings":["University of California, Davis, Davis, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Davis, Davis, CA","institution_ids":["https://openalex.org/I84218800"]}]},{"author_position":"last","author":{"id":null,"display_name":"Robert Weiss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Weiss","raw_affiliation_strings":["University of California, Davis, Davis, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Davis, Davis, CA","institution_ids":["https://openalex.org/I84218800"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"6_suppl","first_page":"411","last_page":"411"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.4287000000476837,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.4287000000476837,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11841","display_name":"Nuclear Structure and Function","score":0.4041000008583069,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.015699999406933784,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/xpo1","display_name":"CRM1","score":0.8920000195503235},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.8600000143051147},{"id":"https://openalex.org/keywords/selinexor","display_name":"selinexor","score":0.9800000190734863},{"id":"https://openalex.org/keywords/selective-inhibitor-of-nuclear-export","display_name":"selective inhibitor of nuclear export","score":0.9120000004768372},{"id":"https://openalex.org/keywords/nuclear-export-inhibition","display_name":"nuclear export inhibition","score":0.7170000076293945},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.7059999704360962},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.9599999785423279},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.890999972820282},{"id":"https://openalex.org/keywords/abt-737","display_name":"ABT-737","score":0.8790000081062317},{"id":"https://openalex.org/keywords/xenograft-tumor-growth","display_name":"xenograft tumor growth","score":0.765999972820282},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.4749999940395355}],"concepts":[{"id":"https://openalex.org/C54757728","wikidata":"https://www.wikidata.org/wiki/Q3511067","display_name":"Nuclear export signal","level":4,"score":0.7578868865966797},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5988492965698242},{"id":"https://openalex.org/C2777336224","wikidata":"https://www.wikidata.org/wiki/Q3193641","display_name":"Karyopherin","level":5,"score":0.5774399638175964},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5503479838371277},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5172020196914673},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.49927282333374023},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4882946014404297},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4745180010795593},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4448127746582031},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4354853332042694},{"id":"https://openalex.org/C2780114586","wikidata":"https://www.wikidata.org/wiki/Q40260","display_name":"Cell nucleus","level":3,"score":0.3151562809944153},{"id":"https://openalex.org/C2780723820","wikidata":"https://www.wikidata.org/wiki/Q1934178","display_name":"Nucleus","level":2,"score":0.31312471628189087},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30930399894714355},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2681432366371155},{"id":"https://openalex.org/C59157529","wikidata":"https://www.wikidata.org/wiki/Q994741","display_name":"Nuclear transport","level":4,"score":0.24861827492713928},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2293553352355957},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1555541753768921},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07353845238685608}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.6_suppl.411","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.411","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.6_suppl.411","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2064370962","https://openalex.org/W2002717016","https://openalex.org/W2596830793","https://openalex.org/W7095334595","https://openalex.org/W2291647476","https://openalex.org/W2601033137","https://openalex.org/W2589653073","https://openalex.org/W2979663888","https://openalex.org/W3207790531","https://openalex.org/W2017630738"],"abstract_inverted_index":{"411":[0],"Background:":[1],"The":[2,98,123],"currently":[3,91],"available":[4,73],"targeted":[5],"therapies":[6],"for":[7,22,28,131,141,256,287],"RCC":[8,99,167,171,225,231,288,321],"have":[9,33],"had":[10],"limited":[11],"success,":[12],"so":[13],"it":[14,180,194],"is":[15,90],"imperative":[16],"to":[17,127,207,218,269,318],"discover":[18],"new":[19,29,284],"therapeutic":[20,285],"approaches":[21],"metastatic":[23],"RCC.":[24],"In":[25,169,266],"a":[26,84,106,184,247,260,283],"search":[27],"such":[30],"targets,":[31],"we":[32,67],"identified":[34],"inhibitors":[35,88,277],"of":[36,47,64,76,86,273,294,298,303,312],"CRM1":[37,65,87,153,261,304],"(XPO1,":[38],"exportin1),":[39],"the":[40,45,53,61,80,177,191,208,219,254,271,292,295],"major":[41],"karyopherin":[42],"that":[43,89],"mediates":[44],"export":[46,297],"most":[48],"tumor":[49,145,300,327],"suppressor":[50],"proteins":[51],"from":[52],"nucleus.":[54,209],"To":[55],"expand":[56],"our":[57],"initial":[58],"work":[59],"on":[60,291],"first":[62],"generation":[63],"inhibitors,":[66],"now":[68],"evaluate":[69],"KPT-330,":[70,117],"an":[71,197],"orally":[72,229],"Selective":[74],"Inhibitor":[75],"Nuclear":[77],"Export":[78],"(SINE),":[79],"best":[81],"tolerated":[82],"among":[83],"series":[85],"in":[92,165,176,190,201,221,233,251,320,324,330],"phase":[93],"I":[94],"clinical":[95],"trials.":[96],"Methods:":[97],"cell":[100,112,185,322],"lines":[101,323],"(Caki-1":[102],"and":[103,105,118,129,144,155,189,213,215,224,263,309,326],"786-O)":[104],"primary":[107],"normal":[108],"human":[109],"kidney":[110],"(NHK)":[111],"line":[113],"were":[114,121,125,137],"treated":[115,138],"with":[116,139,246,259,275],"MTT":[119],"assays":[120],"performed.":[122],"cells":[124],"subjected":[126],"immunofluorescence":[128],"immunoblotting":[130],"appropriate":[132],"proteins.":[133],"Caki-1":[134],"xenograft":[135,234],"mice":[136,235],"KPT-330":[140,150,210,227,243,274],"15":[142],"days,":[143],"volume":[146],"was":[147,174,205],"assessed.":[148],"Results:":[149],"selectively":[151],"attenuated":[152],"levels":[154],"caused":[156],"dose-dependent":[157],"toxicity":[158],"(EC50":[159],"<":[160,240],"1":[161],"\u00b5M)":[162],"through":[163],"apoptosis":[164,319],"all":[166],"cells.":[168,226],"untreated":[170],"cells,":[172,203],"p21":[173,204,214],"localized":[175],"nucleus,":[178],"where":[179,193],"likely":[181],"functions":[182,195],"as":[183,196],"cycle":[186],"arrest":[187],"protein,":[188],"cytosol,":[192],"anti-apoptotic":[198],"protein.":[199],"However,":[200],"NHK":[202,223],"confined":[206,216],"increased":[211],"p53":[212],"them":[217],"nucleus":[220],"both":[222],"given":[228],"inhibited":[230],"growth":[232,328],"(85.3":[236],"%":[237],"inhibition,":[238],"p":[239],"0.001).":[241],"Moreover,":[242],"showed":[244],"synergism":[245],"Bcl-2":[248,264,276],"inhibitor":[249,262],"ABT-737":[250],"vitro,":[252],"indicating":[253],"potential":[255],"combination":[257,272],"therapy":[258],"inhibitor.":[265],"vivo":[267],"studies":[268],"test":[270],"are":[278],"ongoing.":[279],"Conclusions:":[280],"We":[281],"introduce":[282],"approach":[286],"treatment":[289],"based":[290],"inhibition":[293,329],"nuclear":[296,307],"key":[299,314],"suppressors.":[301],"Inhibition":[302],"causes":[305],"forced":[306],"retention,":[308],"thereby":[310],"activation,":[311],"several":[313],"p53-pathway":[315],"proteins,":[316],"leading":[317],"vitro":[325],"vivo.":[331]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-03-03T00:00:00"}